00480 (68)    ONCOLOGY EOD SCHEMAS (165.9)

In situ: noninfiltrating; intraepithelial
 Intraductal WITHOUT infiltration
 Lobular neoplasia, grade 3 (LIN 3)

Diagnosis of inflammatory carcinoma
Ulceration of skin of breast
 WITH a clinical description of inflammation, erythema, edema,
 peau d'orange, etc.,
 involving greater than one-third (33%) or more of the skin of the 
 breast
 WITH or WITHOUT dermal lymphatic infiltration
En cuirasse
Lenticular nodule(s)
Satellite nodule(s)

Stated as "Inflammatory carcinoma" with no other information

No evidence of primary tumor

Unknown; extension not stated
 Primary tumor cannot be assessed
 Not documented in patient record
Death Certificate Only

Paget disease of nipple WITHOUT underlying tumor

Paget disease of nipple WITH underlying DCIS tumor

Any size tumor
Confined to breast tissue and fat including nipple and/or areola
 Localized, NOS
EXCLUDES: skin invasion of breast, nipple and areola (see code 200)

Any size tumor
and/or areola
Attachment or fixation to pectoral muscle(s) or underlying tumor
 Deep fixation
 Invasion of
Pectoral fascia or muscle(s)
Subcutaneous tissue
Local infiltration of dermal lymphatics adjacent to primary tumor
involving skin by direct extension
Skin infiltration of primary breast including skin of nipple 

Invasion of (or fixation to)
Chest wall
Intercostal or serratus anterior muscle(s)
Rib(s)

Extensive skin involvement
Satellite nodule(s)
Skin edema
Ulceration of skin of breast
 WITHOUT a stated diagnosis of inflammatory carcinoma
 WITH or WITHOUT dermal lymphatic filtration
Edema of skin
En cuirasse
Erythema
Inflammation of skin
Lenticular nodule(s)
Peau d'orange ("pigskin")

Diagnosis of inflammatory carcinoma
Ulceration of skin of breast
 WITH a clinical description of inflammation, erythema, edema, peau
d'orange, etc.,
 involving less than or equal to one-third (33%) of the skin of the
breast or percentage not stated
 WITH or WITHOUT dermal lymphatic infiltration
En cuirasse
Satellite nodule(s)
Skin edema

300 + (400 OR 450)

No clinical regional lymph node involvement

CLINICAL assessment only
Fixed/matted axillary (level I and II) (ipsilateral)

CLINICAL assessment only
Internal mammary node(s), ipsilateral
 WITHOUT axillary (level I and II) lymph node(s), ipsilateral

Infraclavicular lymph node(s) (subclavicular) (level III 
 axillary node(s)) (apical), ipsilateral
 WITH or WITHOUT axillary (level I and II) nodes(s)
 WITHOUT internal mammary node

Internal mammary node(s), ipsilateral, clinically apparent
 including infraclavicular
 (On imaging or clinical exam)
 WITH axillary (level I, II, or III) lymph node(s), ipsilateral

Supraclavicular node(s), ipsilateral

Regional lymph node(s), NOS
 Lymph node(s), NOS

Unknown; regional lymph node(s) not stated
 Regional lymph node(s) cannot be assessed
 Not documented in patient record
Death Certificate Only

PATHOLOGICAL assessment only
ITCs only (malignant cell clusters no larger than 0.2 mm) in 
 regional lymph node(s)

PATHOLOGICAL assessment only
Positive molecular findings by reverse transcriptase polymerase 
 chain reaction (RT-PCR), no ITCs detected

No regional lymph node involvement pathologically
 (lymph nodes removed and pathologically negative)
 WITHOUT ITCs or ITC testing unknown

Micrometastasis, less than or equal to 2 mm
 Axillary (level I and II) lymph node(s), ipsilateral
 Detected by IHC or H&E (At least one micrometastasis greater than 0.2mm
 or more than 200 cells)
Micrometastasis, NOS

CLINICAL assessment only
Clinically positive movable axillary (level I and II) lymph node(s)
 ipsilateral
 Positive needle core biopsy/FNA

PATHOLOGICAL assessment only
Positive axillary (level I and II) lymph node(s), ipsilateral
 WITH more than micrometastasis
 (At least one metastasis greater than 2 mm, or size of
  metastasis not stated)
WITHOUT internal mammary lymph node(s) or not stated

PATHOLOGICAL assessment only
Internal mammary node(s), ipsilateral, positive on sentinel node
 biopsy but not clinically apparent
 (No positive imaging or clinical exam)
 WITHOUT axillary lymph node(s), ipsilateral

PATHOLOGICAL assessment only
Internal mammary node(s), ipsilateral, positive on sentinel node
 biopsy not clinically apparent
 (No positive imaging or clinical exam)
 WITH axillary lymph node(s), ipsilateral

No distant metastasis
 Unknown if distant metastasis

No clinical or radiographic evidence of distant mets
Tumor cells found in circulating blood, bone marrow or other distant
 lymph node tissue less than or equal to 0.2mm

Distant lymph node(s)
 Axillary (contralateral or bilateral)
 Cervical, NOS
 Fixed/matted axillary (level I and II) (contralateral or bilateral)
 Infraclavicular (subclavicular) (contralateral or bilateral)
 Internal mammary (parasternal) (contralateral or bilateral)
 Intramammary (contralateral or bilateral)
 Supraclavicular (transverse cervical) (contralateral or bilateral)
 Distant lymph node(s), NOS

Skin over
Contralateral (opposite) breast-if stated as metastatic
Lung
Ovary
Satellite nodule(s) in skin other than primary breast
Carcinomatosis
Distant metastasis WITH or WITHOUT distant lymph node(s)
Distant metastasis, NOS
 Axilla
 Contralateral (opposite) breast
 Sternum
 Upper abdomen
Further contiguous extension
Distant metastasis
Adrenal (suprarenal) gland
Bone other than adjacent rib

Death Certificate Only